EBS FY 2008 Earnings — Emergent BioSolutions Inc. Revenue & Financial Results | Market Cap Arena

EBSEmergent BioSolutions Inc.

$425M

FY 2008 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$179M-2.4% YoY

Gross Profit

$144M80.9% margin

Operating Income

$30M16.8% margin

Net Income

$21M11.6% margin

EPS (Diluted)

$0.68

Cash Flow

Operating Cash Flow

$7M

Free Cash Flow

-$13M

Stock-Based Comp.

$3M

Balance Sheet

Total Assets

$291M

Total Liabilities

$91M

Stockholders' Equity

$199M

Cash & Equivalents

$91M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$179M	$183M	-2.4%
Gross Profit	$144M	$143M	+1.3%
Operating Income	$30M	$33M	-9.6%
Net Income	$21M	$23M	-9.8%